Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 08, 2021

SELL
$181.39 - $202.99 $574,099 - $642,463
-3,165 Closed
0 $0
Q2 2021

Aug 09, 2021

BUY
$187.49 - $221.1 $37,498 - $44,220
200 Added 6.75%
3,165 $638,000
Q1 2021

May 12, 2021

BUY
$207.02 - $241.31 $94,194 - $109,796
455 Added 18.13%
2,965 $637,000
Q4 2020

Feb 12, 2021

SELL
$207.01 - $276.09 $87,979 - $117,338
-425 Reduced 14.48%
2,510 $593,000
Q3 2020

Nov 06, 2020

SELL
$255.65 - $303.1 $3.46 Million - $4.11 Million
-13,550 Reduced 82.2%
2,935 $799,000
Q2 2020

Aug 07, 2020

SELL
$225.48 - $295.8 $100 Million - $131 Million
-443,855 Reduced 96.42%
16,485 $4.79 Million
Q1 2020

May 08, 2020

SELL
$199.77 - $247.81 $4.3 Million - $5.34 Million
-21,530 Reduced 4.47%
460,340 $110 Million
Q4 2019

Feb 05, 2020

SELL
$166.71 - $223.91 $22.2 Million - $29.9 Million
-133,350 Reduced 21.68%
481,870 $106 Million
Q3 2019

Nov 05, 2019

BUY
$166.23 - $187.09 $17.5 Million - $19.7 Million
105,030 Added 20.59%
615,220 $104 Million
Q2 2019

Aug 02, 2019

SELL
$164.61 - $190.37 $1.74 Million - $2.02 Million
-10,585 Reduced 2.03%
510,190 $93.6 Million
Q1 2019

May 10, 2019

BUY
$163.73 - $194.7 $8.16 Million - $9.71 Million
49,855 Added 10.59%
520,775 $95.8 Million
Q4 2018

Feb 14, 2019

SELL
$151.91 - $192.21 $12.8 Million - $16.2 Million
-84,160 Reduced 15.16%
470,920 $78 Million
Q3 2018

Nov 14, 2018

SELL
$167.73 - $192.74 $21.6 Million - $24.8 Million
-128,730 Reduced 18.83%
555,080 $0
Q2 2018

Aug 14, 2018

BUY
$145.72 - $169.96 $23.8 Million - $27.8 Million
163,480 Added 31.42%
683,810 $116 Million
Q1 2018

May 15, 2018

BUY
$151.6 - $177.13 $502,554 - $587,185
3,315 Added 0.64%
520,330 $84.8 Million
Q4 2017

Feb 14, 2018

BUY
$137.28 - $155.55 $7.05 Million - $7.98 Million
51,325 Added 11.02%
517,015 $77.5 Million
Q3 2017

Nov 09, 2017

SELL
$148.13 - $162.24 $3.65 Million - $4 Million
-24,655 Reduced 5.03%
465,690 $70.8 Million
Q2 2017

Aug 10, 2017

BUY
N/A
490,345
490,345 $63.2 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $119B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Times Square Capital Management, LLC Portfolio

Follow Times Square Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Times Square Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Times Square Capital Management, LLC with notifications on news.